Lv11
78 积分 2024-01-23 加入
LRP4 mutations promote tumour progression and resistance to anti-PD-1 therapy in recurrent hepatocellular carcinoma
2小时前
求助中
Acetate reprogrammes tumour metabolism and promotes PD-L1 expression and immune evasion by upregulating c-Myc
3个月前
已完结
Efficacy and safety of low dose radiotherapy(LDRT) concurrent atezolizumab(Atezo) plus chemotherapy as first line(1L) therapy for ES-SCLC: primary analysis of phase Ⅱ MATCH study
7个月前
已关闭
Carboplatin, etoposide, bevacizumab, and atezolizumab in patients with extensive-stage SCLC-GOIRC-01-2019 CeLEBrATE trial
7个月前
已完结
Benmelstobart with anlotinib plus chemotherapy as first-line therapy for ES-SCLC: a randomized, double-blind, phase Ⅲ trial
7个月前
已完结
Low serum apolipoprotein A1 impairs antitumor immunity of CD8+ T cells via the HIF-1α-glycolysis pathway
7个月前
已完结
The lactate receptor GPR81 promotes breast cancer growth via a paracrine mechanism involving antigen-presenting cells in the tumor microenvironment
8个月前
已完结
Targeting tumor-intrinsic SLC16A3 to enhance anti-PD-1 efficacy via tumor immune microenvironment reprogramming
8个月前
已完结
A novel model for predicting prognosis and response to immunotherapy in nasopharyngeal carcinoma patients
8个月前
已完结
Tumor-targeted therapy with BRAF-inhibitor recruits activated dendritic cells to promote tumor immunity in melanoma
9个月前
已完结
Enhanced Expression of Hepatocyte Growth Factor by Pulmonary Ischemia–Reperfusion Injury in the Rat
皖公网安备34019202002308
